M. Resche Rigon
4 Papers
M. Resche Rigon is an academic researcher. The author has contributed to research in topics: Vasculitis & Rheumatology. The author has an hindex of 3, co-authored 4 publications.
Chat about Author
Papers
Efficacy of anti-TNF alpha in severe and/or refractory Behçet's disease: Multicenter study of 124 patients
H. Vallet,Sophie Rivière,Alice Sanna,Alban Deroux,Guillaume Moulis,Olga Addimanda,Carlo Salvarani,Marc Lambert,Philip Bielefeld,Pascal Sève,Jean Sibilia,Jl Pasquali,J.B. Fraison,Isabelle Marie,Laurent Perard,L. Bouillet,F. Cohen,Damien Sène,Yoland Schoindre,O Lidove,P. Le Hoang,Eric Hachulla,Olivier Fain,Xavier Mariette,Thomas Papo,Bertrand Wechsler,Bahram Bodaghi,M. Resche Rigon,Patrice Cacoub,D. Saadoun +29 more
TL;DR: Anti-TNF alpha therapy is efficient in all severe and refractory BD manifestations and appears to be similar regardless of the anti-T NF agent used (infliximab or adalimumab).
199
OP0235 Interferon-free antivirals for hepatitis c virus-associated cryoglobulinemia vasculitis: a long-term follow-up study
Patrice Cacoub,Si Nafa Si Ahmed,Yasmina Ferfar,Stanislas Pol,Dominique Thabut,Christophe Hézode,Laurent Alric,Cloé Comarmond,Gaafar Ragab,L. Quatuccio,Mohamed Tharwat Hegazy,Thierry Poynard,M. Resche Rigon,D. Saadoun +13 more
TL;DR: The different DAA combinations showed high response rates of HCV-CryoVas symptoms, the tolerance was good, and the mortality rate was very low, the authors identified prognosis factors of response to DAA.
Peg-IFNα/ribavirin/protease inhibitor combination in hepatitis C virus associated mixed cryoglobulinemia vasculitis: results at week 24
David Saadoun,M. Resche Rigon,Valérie Thibault,M. Longuet,Stanislas Pol,François Blanc,Gilles Pialoux,A. Karras,D. Bazin-Karra,C. Cazorla,Daniel Vittecoq,Lucile Musset,Olivier Decaux,Jean-Marc Ziza,Olivier Lambotte,Patrice Cacoub +15 more
TL;DR: Peg-IFNα/ribavirin/protease inhibitor combination seems highly effective in HCV-MC, and such therapeutic regimen should be administered cautiously considering the high rate of side effects.
Hepatitis C virus–associated polyarteritis nodosa
D. Saadoun,Benjamin Terrier,O. Semoun,Damien Sène,Thierry Maisonobe,Lucile Musset,Z. Amoura,M. Resche Rigon,Patrice Cacoub +8 more
TL;DR: The main characteristics and outcome of polyarteritis nodosa (PAN)–type vasculitis associated with hepatitis C virus (HCV) are analyzed.